Efficacy and safety of brexpiprazole in schizophrenia: Meta-analysis of three double-blind, randomized, placebo-controlled phase 3 studies

被引：0
|
作者：
Weiss, C. [1 ]
Zhang, P. [2 ]
Hakala, M. J. [3 ]
Skuban, A. [4 ]
Weiller, E. [5 ]
机构：
[1] Otsuka Pharmaceut Dev & Commercializat Inc, Global Med Affairs, Princeton, NJ USA
[2] Otsuka Pharmaceut Dev & Commercializat Inc, Biostat, Princeton, NJ USA
[3] H Lundbeck & Co AS, ICR Psychiat, Valby, Denmark
[4] Otsuka Pharmaceut Dev & Commercializat Inc, Global Clin Dev, Princeton, NJ USA
[5] H Lundbeck & Co AS, Med Affairs, Valby, Denmark
来源：
EUROPEAN PSYCHIATRY | 2016年 / 33卷
关键词：
D O I：
10.1016/j.eurpsy.2016.01.100
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
FC96
引用
收藏
页码：S109 / S109
页数：1
相关论文
共 50 条
  • [1] Efficacy of brexpiprazole in patients with acute schizophrenia: Review of three randomized, double-blind, placebo-controlled studies
    Correll, Christoph U.
    Skuban, Aleksandar
    Hobart, Mary
    Ouyang, John
    Weiller, Emmanuelle
    Weiss, Catherine
    Kane, John M.
    [J]. SCHIZOPHRENIA RESEARCH, 2016, 174 (1-3) : 82 - 92
  • [2] Comparison of the efficacy and safety of 4 and 2 mg/day brexpiprazole for acute schizophrenia: a meta-analysis of double-blind, randomized placebo-controlled trials
    Kishi, Taro
    Oya, Kazuto
    Matsui, Yuki
    Nomura, Ikuo
    Sakuma, Kenji
    Okuya, Makoto
    Matsuda, Yuki
    Fujita, Kiyoshi
    Funahashi, Toshihiko
    Yoshimura, Reiji
    Iwata, Nakao
    [J]. NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2018, 14 : 2519 - 2530
  • [3] Efficacy and Safety of Brexpiprazole for the Treatment of Acute Schizophrenia: A 6-Week Randomized, Double-Blind, Placebo-Controlled Trial
    Correll, Christoph U.
    Skuban, Aleksandar
    Ouyang, John
    Hobart, Mary
    Pfister, Stephanie
    McQuade, Robert D.
    Nyilas, Margaretta
    Carson, William H.
    Sanchez, Raymond
    Eriksson, Hans
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2015, 172 (09): : 870 - 880
  • [4] Meta-analysis of randomized, double-blind, placebo-controlled, efficacy and safety studies of mirtazapine versus amitriptyline in major depression
    Stahl, S
    Zivkov, M
    Reimitz, PE
    Panagides, J
    Hoff, W
    [J]. ACTA PSYCHIATRICA SCANDINAVICA, 1997, 96 : 22 - 30
  • [5] Adjunctive memantine for schizophrenia: a meta-analysis of randomized, double-blind, placebo-controlled trials
    Zheng, W.
    Li, X-H.
    Yang, X-H.
    Cai, D-B.
    Ungvari, G. S.
    Ng, C. H.
    Wang, S-B.
    Wang, Y-Y.
    Ning, Y-P.
    Xiang, Y-T.
    [J]. PSYCHOLOGICAL MEDICINE, 2018, 48 (01) : 72 - 81
  • [6] Adjunctive Fluvoxamine for Schizophrenia: A Meta-analysis of Randomized Double-Blind, Placebo-Controlled Trials
    Zheng, Wei
    Xiang, Ying-Qiang
    Cai, Dong-Bin
    Yang, Xin-Hu
    Zhang, Ling
    Lu, Xiao-Bing
    Tong, Yan-Ming
    Huang, Xiong
    Ungvari, Gabor S.
    Sim, Kang
    Ning, Yu-Ping
    Xiang, Yu-Tao
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2020, 40 (04) : 386 - 390
  • [7] Adjunctive Reboxetine for Schizophrenia: Meta-analysis of Randomized Double-blind, Placebo-controlled Trials
    Zheng, Wei
    Li, Xian-Bin
    Shi, Zhan-Ming
    Yang, Xin-Hu
    Cai, Dong-Bin
    Ng, Chee H.
    Ungvari, Gabor S.
    Liu, Wei-Jian
    Wu, Yu-Jie
    Wang, Yuan-Yuan
    Ning, Yu-Ping
    Xiang, Yu-Tao
    [J]. PHARMACOPSYCHIATRY, 2020, 53 (01) : 5 - 13
  • [8] Adjunctive celecoxib for schizophrenia: A meta-analysis of randomized, double-blind, placebo-controlled trials
    Zheng, Wei
    Cai, Dong-Bin
    Yang, Xin-Hu
    Ungvari, Gabor S.
    Ng, Chee H.
    Mueller, Norbert
    Ning, Yu-Ping
    Xiang, Yu-Tao
    [J]. JOURNAL OF PSYCHIATRIC RESEARCH, 2017, 92 : 139 - 146
  • [9] Adjunctive azapirone for schizophrenia: A meta-analysis of randomized, double-blind, placebo-controlled trials
    Zheng, Wei
    Li, Xiao-Hong
    Cai, Dong-Bin
    Yang, Xin-Hu
    Ungvari, Gabor S.
    Ng, Chee H.
    Ning, Yu-Ping
    Xiang, Yu-Tao
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2018, 28 (01) : 149 - 158
  • [10] Efficacy and safety of noradrenalin reuptake inhibitor augmentation therapy for schizophrenia: A meta-analysis of double-blind randomized placebo-controlled trials
    Kishi, Taro
    Mukai, Tomohiko
    Matsuda, Yuki
    Moriwaki, Masatsugu
    Iwata, Nakao
    [J]. JOURNAL OF PSYCHIATRIC RESEARCH, 2013, 47 (11) : 1557 - 1563
12345